CFG
MRNA icon

Citizens Financial Group’s Moderna MRNA Stock Holding History

Citizens Financial Group’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$212K Buy
+3,025
New +$157K ﹤0.01% 983
2020
Q3 		– Sell
-308
Closed -$20K – 659
2020
Q2 		$20K Buy
+308
New +$16.9K ﹤0.01% 626

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Citizens Financial Group's MRNA Position: Q2 2026 in Review

Citizens Financial Group opened a new position in Moderna (MRNA) in Q2 2026: 3,025 shares worth $212K. The stake represents ﹤0.01% of the portfolio and ranks #983 among its holdings. This is a return to the name: Citizens Financial Group previously reported a position in MRNA as recently as Q2 2020.

Citizens Financial Group first reported a position in MRNA in Q2 2020 and has held it in 2 quarters since. 784 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Citizens Financial Group held 3,025 shares of Moderna worth $212K as of Q2 2026.
  • Moderna was a new Citizens Financial Group position in Q2 2026.
  • Moderna made up ﹤0.01% of Citizens Financial Group's portfolio in Q2 2026, its #983 holding.
  • Citizens Financial Group first reported a position in Moderna in Q2 2020 and has held it in 2 quarters since.
  • 784 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Citizens Financial Group's 13F filing for Q2 2026, filed 7 Aug 2026.